Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6. This is a minor version bump and does not change study content, eligibility, or results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision/version label was updated to v3.6.5, signaling a new build of the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page revision number was updated from v3.6.3 to v3.6.4, reflecting a minor update to the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page version was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. There are no visible changes to the study content or data reflected in the provided information.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's Revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page. This update affects only the version label displayed on the page and does not modify its content.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now indicates that recruitment is closed (no longer looking for participants). New help and navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), and a UI revision note (Revision: v3.6.0) has been introduced.SummaryDifference0.5%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.